Abstract | INTRODUCTION: MATERIAL AND METHODS: We conducted a case-control study with patients admitted in our hospital with subtrochanteric or diaphyseal femur fracture in a period of five and a half years. After applying the exclusion criteria, the 92 fractures (91 patients) were classified as typical or atypical. The determination of prior bisphosphonate treatment was obtained through consultation of the individual medical history. RESULTS: We found 11 atypical fractures (10 patients) and 81 typical fractures (81 patients). The median age of both groups was statistically different (72 years - atypical vs. 80 years - typical, p < 0.01). The reason for the use of bisphosphonates was 0.60 in atypical fractures and 0.01 in typical, and an odds ratio of 101.1 was obtained (p < 0.01). DISCUSSION: Our results are supported and are in agreement with published studies relating to the occurrence of atypical femoral fractures associated with treatment with bisphosphonates. CONCLUSION: Despite the small number of cases it was possible to demonstrate a statistically significant relation between atypical femoral fractures and treatment with bisphosphonates. One should note that these atypical fractures occurred in patients significantly younger than patients with typical fractures.
|
Authors | Nuno Geada, Inês Mafra, Rogério Barroso, José Franco |
Journal | Acta medica portuguesa
(Acta Med Port)
2014 Nov-Dec
Vol. 27
Issue 6
Pg. 704-9
ISSN: 1646-0758 [Electronic] Portugal |
Vernacular Title | Fracturas Femorais Atípicas e o Tratamento com Bifosfonatos: É um Factor de Risco? |
PMID | 25641284
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Aged
- Aged, 80 and over
- Case-Control Studies
- Diphosphonates
(adverse effects)
- Female
- Femoral Fractures
(chemically induced, epidemiology)
- Humans
- Male
- Retrospective Studies
- Risk Factors
|